Cybin Inc. (HELP) details $511,720 exempt stock option plan terms
Rhea-AI Filing Summary
Cybin Inc., an Ontario-based biotechnology corporation, is conducting a private offering of stock options under the Rule 506(b) exemption of Regulation D. The options could generate up to $511,720 in proceeds, representing the maximum potential proceeds from option exercises.
The options are exercisable at $6.61 per share until June 30, 2036, and vest in seven quarterly tranches beginning July 1, 2026. Total amount sold is reported as $0, and the notice lists $0 in finders’ fees.
Positive
- None.
Negative
- None.
Key Figures
Maximum potential proceeds: $511,720 USD
Total amount sold: $0 USD
Exercise price: $6.61 per share
+4 more
7 metrics
Maximum potential proceeds
$511,720 USD
Total remaining to be sold; total offering amount represents maximum potential proceeds from option exercises
Total amount sold
$0 USD
Reported sales to date in the exempt stock option offering
Exercise price
$6.61 per share
Stock options exercisable at $6.61 per share until June 30, 2036
Option expiration date
June 30, 2036
Last date options may be exercised under the plan
Vesting commencement
July 1, 2026
Options vesting in seven quarterly tranches beginning July 1, 2026
Exemption relied upon
Rule 506(b)
Federal exemption claimed for this exempt offering of securities
Date of first sale
2026-07-01
Date of first sale as listed in the notice
Key Terms
Rule 506(b), Regulation D exemption, stock options, accredited investors, +1 more
5 terms
Rule 506(b) regulatory
"6. Federal Exemption(s) and Exclusion(s) Claimed ... X | Rule 506(b)"
Rule 506(b) is a U.S. securities exemption that lets companies sell shares or debt privately without full public registration, provided sales are primarily to accredited investors, up to 35 non‑accredited but financially knowledgeable buyers, and there is no public advertising or solicitation. It matters to investors because offerings under 506(b) usually include less public disclosure than registered securities—like buying from a private seller rather than a retail store—so buyers must do more of their own fact‑checking and rely on their financial sophistication.
Regulation D exemption regulatory
"Certifying that, if the issuer is claiming a Regulation D exemption for the offering..."
stock options financial
"Stock options exercisable at $6.61 per share until June 30, 2036, vesting in seven quarterly tranches"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
accredited investors regulatory
"Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors"
Accredited investors are individuals or entities considered to have enough financial knowledge and resources to understand and handle more complex and risky investments. They are often allowed to participate in private investment opportunities that are not available to the general public, similar to how experienced players might access exclusive clubs or events. This status helps ensure that investors can manage potential risks and rewards appropriately.
covered securities regulatory
"if the securities that are the subject of this Form D are covered securities for purposes of NSMIA"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What type of securities is Cybin Inc. (HELP) offering in this Form D?
Cybin Inc. is offering stock options in a private placement under Rule 506(b). The options are exercisable at $6.61 per share, expire on June 30, 2036, and vest in seven quarterly tranches starting July 1, 2026.
How large is Cybin Inc. (HELP)’s exempt stock option offering?
The notice shows a maximum potential offering size of $511,720. Total amount sold is currently reported as $0, with $511,720 listed as the total remaining to be sold, representing potential proceeds upon exercise of the options.
What are the exercise price and term of Cybin Inc. (HELP)’s options?
Cybin’s stock options carry an exercise price of $6.61 per share and are exercisable until June 30, 2036. These terms define the cost per share and final date on which holders may exercise the options.
When does vesting begin for Cybin Inc. (HELP)’s stock options and how is it structured?
Vesting begins on July 1, 2026 and occurs in seven quarterly tranches. This means the options become exercisable in stages over roughly seven quarters rather than all at once, aligning with the schedule described in the notice.
What exemptions and fees are disclosed for Cybin Inc. (HELP)’s offering?
The company relies on the Rule 506(b) exemption under Regulation D for this offering. The filing lists finders’ fees of $0 and does not indicate any separate sales commissions amounts in the disclosed fields.
When is the date of first sale for Cybin Inc. (HELP)’s exempt offering?
The notice identifies a Date of First Sale of July 1, 2026. At the time of the submission, the total amount sold is reported as $0, with the full $511,720 shown as remaining to be sold.